Related Experiment Videos
Efficacy of bretylium tosylate for ventricular tachycardia
S Chandrasekaran1, J S Steinberg
1Department of Medicine, St. Luke's-Roosevelt Hospital Center, Columbia University School of Physicians & Surgeons, New York, New York 10025, USA.
The American Journal of Cardiology
|March 12, 1999
Abstract:
In 20 patients with inducible ventricular tachycardia (VT), intravenous bretylium tosylate infused as a 10-mg/kg bolus followed by 2 mg/min caused no change in refractory periods and did not suppress inducibility of VT. The use of bretylium for the treatment of VT should be reexamined.